Mechanism of p53 stabilization by ATM after DNA damage

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Cell Cycle

• Publication date

  2010-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4161/cc.9.3.10556PMID 20081365PMCID PMC2977994
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ATM activates p53 by regulating MDM2 oligomerization and E3 processivity

  2009cited by this paper
• RING domain E3 ubiquitin ligases.

  2009cited by this paper
• Increased radioresistance and accelerated B cell lymphomas in mice with Mdmx mutations that prevent modifications by DNA-damage-activated kinases.

  2009cited by this paper
• Mechanistic insights into active site-associated polyubiquitination by the ubiquitin-conjugating enzyme Ube2g2

  2009cited by this paper
• CBP and p300 are cytoplasmic E4 polyubiquitin ligases for p53

  2009cited by this paper
• Mutations in Fbx4 inhibit dimerization of the SCF(Fbx4) ligase and contribute to cyclin D1 overexpression in human cancer.

  2008cited by this paper
• Structure of the MDM2/MDMX RING domain heterodimer reveals dimerization is required for their ubiquitylation in trans

  2008cited by this paper
• The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.

  2007cited by this paper
• The Mdm2 RING domain C‐terminus is required for supramolecular assembly and ubiquitin ligase activity

  2007cited by this paper
• Distinct roles of Mdm2 and Mdm4 in red cell production.

  2007cited by this paper
• Distinct Roles of MDMX in the Regulation of p53 Response to Ribosomal Stress

  2007cited by this paper
• p53 in health and disease

  2007cited by this paper
• Suprafacial orientation of the SCFCdc4 dimer accommodates multiple geometries for substrate ubiquitination.

  2007cited by this paper
• [In-vivo activation of the p53 pathway by small-molecule antagonists of MDM2].

  2007cited by this paper
• A ubiquitin ligase transfers preformed polyubiquitin chains from a conjugating enzyme to a substrate

  2007cited by this paper
• Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development.

  2006cited by this paper
• MDMX regulation of p53 response to ribosomal stress

  2006cited by this paper
• Differential Roles of ATM- and Chk2-Mediated Phosphorylations of Hdmx in Response to DNA Damage

  2006cited by this paper
• Divorcing ARF and p53: an unsettled case

  2006cited by this paper
• A mouse p53 mutant lacking the proline-rich domain rescues Mdm4 deficiency and provides insight into the Mdm2-Mdm4-p53 regulatory network.

  2006cited by this paper
• Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo.

  2006cited by this paper
• Structural Basis of Competitive Recognition of p53 and MDM2 by HAUSP/USP7: Implications for the Regulation of the p53–MDM2 Pathway

  2006cited by this paper
• Regulation of MDMX nuclear import and degradation by Chk2 and 14‐3‐3

  2006cited by this paper
• Critical role for Daxx in regulating Mdm2

  2006cited by this paper
• Tissue-Specific Differences of p53 Inhibition by Mdm2 and Mdm4

  2006cited by this paper
• Ser18 and 23 phosphorylation is required for p53‐dependent apoptosis and tumor suppression

  2006cited by this paper
• A UbcH5/ubiquitin noncovalent complex is required for processive BRCA1-directed ubiquitination.

  2006cited by this paper
• Mechanistic insight into the allosteric activation of a ubiquitin-conjugating enzyme by RING-type ubiquitin ligases.

  2005cited by this paper
• Phosphorylation of Hdmx mediates its Hdm2- and ATM-dependent degradation in response to DNA damage.

  2005cited by this paper
• Glycogen Synthase Kinase 3-Dependent Phosphorylation of Mdm2 Regulates p53 Abundance

  2005cited by this paper
• MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein.

  2005cited by this paper
• Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2.

  2005cited by this paper
• ATM and Chk2‐dependent phosphorylation of MDMX contribute to p53 activation after DNA damage

  2005cited by this paper
• MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation

  2005cited by this paper
• ATM-Mediated Phosphorylations Inhibit Mdmx/Mdm2 Stabilization by HAUSP in Favor of p53 Activation

  2005cited by this paper
• In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

  2004cited by this paper
• Yin Yang 1 is a negative regulator of p53.

  2004cited by this paper
• Getting into position: the catalytic mechanisms of protein ubiquitylation.

  2004cited by this paper
• Regulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in Vivo*

  2004cited by this paper
• Accelerated MDM2 auto‐degradation induced by DNA‐damage kinases is required for p53 activation

  2004cited by this paper
• Ribosomal Protein L23 Activates p53 by Inhibiting MDM2 Function in Response to Ribosomal Perturbation but Not to Translation Inhibition

  2004cited by this paper
• Inhibition of MDM2-mediated p53 Ubiquitination and Degradation by Ribosomal Protein L5*

  2004cited by this paper
• Defective apoptosis and B‐cell lymphomas in mice with p53 point mutation at Ser 23

  2004cited by this paper
• Essential role of ribosomal protein L11 in mediating growth inhibition‐induced p53 activation

  2004cited by this paper
• The ubiquitin ligase COP1 is a critical negative regulator of p53

  2004cited by this paper
• Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation.

  2003cited by this paper
• Ribosomal Protein L11 Negatively Regulates Oncoprotein MDM2 and Mediates a p53-Dependent Ribosomal-Stress Checkpoint Pathway

  2003cited by this paper
• Critical Role for a Central Part of Mdm2 in the Ubiquitylation of p53

  2003cited by this paper
• Structure of a beta-TrCP1-Skp1-beta-catenin complex: destruction motif binding and lysine specificity of the SCF(beta-TrCP1) ubiquitin ligase.

  2003cited by this paper
• Cell Type- and Promoter-specific Roles of Ser18 Phosphorylation in Regulating p53 Responses*

  2003cited by this paper
• Critical Contribution of the MDM2 Acidic Domain to p53 Ubiquitination

  2003cited by this paper
• ATM and related protein kinases: safeguarding genome integrity

  2003cited by this paper
• Functional role of Mdm2 phosphorylation by ATR in attenuation of p53 nuclear export

  2003cited by this paper
• MDM2 Promotes Ubiquitination and Degradation of MDMX

  2003cited by this paper
• HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53

  2003cited by this paper
• DNA Damage-induced MDMX Degradation Is Mediated by MDM2*

  2003cited by this paper
• Hdmx Protein Stability Is Regulated by the Ubiquitin Ligase Activity of Mdm2*

  2003cited by this paper
• Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2

  2003cited by this paper
• Regulation of HDM2 activity by the ribosomal protein L11.

  2003cited by this paper
• Mdm4 (Mdmx) Regulates p53-Induced Growth Arrest and Neuronal Cell Death during Early Embryonic Mouse Development

  2002cited by this paper
• Tyrosine phosphorylation of Mdm2 by c‐Abl: implications for p53 regulation

  2002cited by this paper
• Hypophosphorylation of Mdm2 Augments p53 Stability

  2002cited by this paper
• MdmX Is a RING Finger Ubiquitin Ligase Capable of Synergistically Enhancing Mdm2 Ubiquitination*

  2002cited by this paper
• Control of biochemical reactions through supramolecular RING domain self-assembly

  2002cited by this paper
• Mutual Dependence of MDM2 and MDMX in Their Functional Inactivation of p53*

  2002cited by this paper
• mdmx is a negative regulator of p53 activity in vivo.

  2002cited by this paper
• ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.

  2001cited by this paper
• A structural basis for processivity

  2001cited by this paper
• Structure of a BRCA1–BARD1 heterodimeric RING–RING complex

  2001cited by this paper
• c-Abl Regulates p53 Levels under Normal and Stress Conditions by Preventing Its Nuclear Export and Ubiquitination

  2001cited by this paper
• Organization, expression, and localization of the murine mdmx gene and pseudogene.

  2001cited by this paper
• Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53.

  2000cited by this paper
• Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases.

  2000cited by this paper
• ATM complexes with HDM2 and promotes its rapid phosphorylation in a p53-independent manner in normal and tumor human cells exposed to ionizing radiation

  2000cited by this paper
• The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites.

  2000cited by this paper
• An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo

  2000cited by this paper
• Recognition of the polyubiquitin proteolytic signal

  2000cited by this paper
• Comparative study of the p53-mdm2 and p53-MDMX interfaces

  1999cited by this paper
• DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation

  1999cited by this paper
• Regulation of p53 Function and Stability by Phosphorylation

  1999cited by this paper
• Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2

  1999cited by this paper
• Enhanced phosphorylation of p53 by ATM in response to DNA damage.

  1998cited by this paper
• Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation

  1997cited by this paper
• DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.

  1997cited by this paper
• MDMX: a novel p53‐binding protein with some functional properties of MDM2.

  1996cited by this paper
• Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53

  1995cited by this paper
• A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia.

  1992cited by this paper

• A Review of Ionizing Radiation-Induced Senescence of Bone Marrow Mesenchymal Stem/Stromal Cells: Mechanisms and Therapeutic Strategies.

  2026cites this paper
• Targeting ATR-CHK1 and ATM-CHK2 Axes in Pancreatic Cancer—A Comprehensive Review of Literature

  2026cites this paper
• Reduced structural rigidity of MDMX protein enhances binding to TP53 mRNA

  2025cites this paper
• Colibactin-producing E. coli promote carcinogenesis of gastroesophageal adenocarcinoma and simultaneously induce autophagy and differentiation

  2025cites this paper
• Association of DNA damage response pathway genes with rheumatoid arthritis risks: a case-control study

  2025cites this paper
• Bypassing the guardian: regulated cell death pathways in p53-mutant cancers

  2025cites this paper
• DNA Damage-Induced Ferroptosis: A Boolean Model Regulating p53 and Non-Coding RNAs in Drug Resistance

  2025cites this paper
• The role of ATM in sodium butyrate-mediated inhibition of macrophage polarization.

  2025cites this paper
• Epstein-Barr virus nuclear antigen 1 (EBNA1) increases the expression levels of MDM2 and MDM4 genes in HeLa cells: a review on MDM2 and MDM4 roles in cancer

  2025cites this paper
• Renal transcriptome-wide analyses in association with kidney black carbon load

  2025cites this paper
• Downregulation of EZH2 Promotes Renal Epithelial Cellular Senescence and Kidney Aging

  2025cites this paper
• The controversial role of senescence-associated secretory phenotype (SASP) in cancer therapy

  2025cites this paper
• Targeting ATR to overcome cisplatin resistance in hepatoblastoma.

  2025cites this paper
• Therapeutic targeting of ubiquitin-specific protease 7 (USP7): Mechanistic insights, dysregulation, and advances in drug discovery.

  2025cites this paper
• From concept to application: Exploring the evolution and potential of DUBTAC technology

  2025cites this paper
• Dual cancers in Ataxia-Telangiectasia: a case report and literature review

  2025cites this paper
• Dual RNA Polymerase I Inhibition with CX-5461 and BMH-21 Synergizes in Breast Cancer by Activating p53-Dependent Stress

  2025cites this paper
• PITAR, a DNA damage-inducible cancer/testis long noncoding RNA, inactivates p53 by binding and stabilizing TRIM28 mRNA

  2024cites this paper
• Differential gene expression in cells with different p53 mutations identifies genome-wide p53 targets and shows distinct modulation of cellular pathways in response to DNA damage

  2024cites this paper
• Plant Compounds Inhibit the Growth of W12 Cervical Precancer Cells Containing Episomal or Integrant HPV DNA; Tanshinone IIA Synergizes with Curcumin in Cervical Cancer Cells

  2024influential citation
• BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism

  2024cites this paper
• Targeted sequencing of DNA/RNA combined with radiomics predicts lymph node metastasis of papillary thyroid carcinoma

  2024cites this paper
• 53BP1-mediated activation of the tumor suppressor p53.

  2024cites this paper
• DNA damage–induced p53 downregulates expression of RAG1 through a negative feedback loop involving miR-34a and FOXP1

  2024cites this paper
• Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies.

  2024cites this paper
• Understanding the molecular mechanism of regeneration through apoptosis-induced compensatory proliferation studies - updates and future aspects

  2024cites this paper
• Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

  2024cites this paper
• Targeting the DNA damage response in cancer

  2024cites this paper
• The crosstalk between non-coding RNAs and cell-cycle events: A new frontier in cancer therapy

  2024cites this paper
• The DNA damage sensor ATM kinase interacts with the p53 mRNA and guides the DNA damage response pathway

  2024cites this paper
• Crosstalk between BER and NHEJ in XRCC4-Deficient Cells Depending on hTERT Overexpression

  2024cites this paper
• Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition

  2023cites this paper
• Drug Discovery Targeting Post-Translational Modifications in Response to DNA Damages Induced by Space Radiation

  2023cites this paper
• Cytomorphic Electrical Circuit Modeling of Tumor Suppressor p53 Protein Pathway

  2023cites this paper
• Beyond Bruton’s tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody–drug conjugates, CAR T-cells, and novel agents

  2023cites this paper
• Exploiting PRMT5 as a target for combination therapy in mantle cell lymphoma characterized by frequent ATM and TP53 mutations

  2023cites this paper
• A heterozygous mutation in UBE2H in a patient with developmental delay leads to an aberrant brain development in zebrafish

  2023cites this paper
• Aspergillus Carneus metabolite Averufanin induced cell cycle arrest and apoptotic cell death on cancer cell lines via inducing DNA damage

  2023cites this paper
• Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia

  2023cites this paper
• p53-Dependent Cytoprotective Mechanisms behind Resistance to Chemo-Radiotherapeutic Agents Used in Cancer Treatment

  2023cites this paper
• Modeling of Intracellular Taurine Levels Associated with Ovarian Cancer Reveals Activation of p53, ERK, mTOR and DNA-Damage-Sensing-Dependent Cell Protection

  2023cites this paper
• DNA-Dependent Protein Kinase Inhibitor Peposertib Potentiates the Cytotoxicity of Topoisomerase II Inhibitors in Synovial Sarcoma Models

  2023cites this paper
• Oscillatory dynamics of p53 pathway in etoposide sensitive and resistant cell lines

  2022cites this paper
• Network analysis reveals that the tumor suppressor lncRNA GAS5 acts as a double-edged sword in response to DNA damage in gastric cancer

  2022cites this paper
• Proton pump inhibitors and sensitization of cancer cells to radiation therapy

  2022cites this paper
• Transcriptome analysis of HEK 293T cells revealed different significance of the depletion of DNA-dependent protein kinase subunits, Ku70, Ku80, and DNA-PKcs.

  2022cites this paper
• MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response

  2022cites this paper
• Targeting the ATM Kinase to Enhance the Efficacy of Radiotherapy and Outcomes for Cancer Patients.

  2022cites this paper
• Targeting the DNA Damage Response and DNA Repair Pathways to Enhance Radiosensitivity in Colorectal Cancer

  2022cites this paper
• A New Insight Into p53-Inhibiting Genes in Epstein–Barr Virus-Associated Gastric Adenocarcinoma

  2022cites this paper
• Combinatorial nanococktails via self-assembling lipid prodrugs for synergistically overcoming drug resistance and effective cancer therapy

  2022cites this paper
• Antiproliferative effects of Artabotrys odoratissimus fruit extract and its bioactive fraction through upregulation of p53/γH2AX signals and G2/M phase arrest in MIA PaCa-2 cells.

  2022cites this paper
• Plasma oncology: Adjuvant therapy for head and neck cancer using cold atmospheric plasma

  2022cites this paper
• Mycoplasma hominis Causes DNA Damage and Cell Death in Primary Human Keratinocytes

  2022cites this paper
• Recent advances in ATM inhibitors as potential therapeutic agents.

  2022cites this paper
• Comparative assessment on the probable mechanisms underlying the hepatorenal toxicity of commercial imidacloprid and hexaflumuron formulations in rats

  2022cites this paper
• Overcoming Chemotherapy Resistance in Germ Cell Tumors

  2022cites this paper
• ATM: Functions of ATM Kinase and Its Relevance to Hereditary Tumors

  2022cites this paper
• XPG in the Nucleotide Excision Repair and Beyond: a study on the different functional aspects of XPG and its associated diseases

  2022cites this paper
• Nucleic Acid Sensing Pathways in DNA Repair Targeted Cancer Therapy

  2022cites this paper
• Intragenic L1 Insertion: One Possibility of Brain Disorder

  2022cites this paper
• Par-4 in Cell Cycle Regulation

  2022cites this paper
• Prognostic Value of the Immunohistochemical Expression of RAD51 and BRCA2 in Gastric Adenocarcinoma

  2022cites this paper
• 3’UTR-dependent dynamic changes in TP53 mRNA localization regulate p53 tumor suppressor activity

  2022cites this paper
• A Critical Role for p53 during the HPV16 Life Cycle

  2022cites this paper
• ATM Modulates Nuclear Mechanics by Regulating Lamin A Levels

  2022cites this paper
• The Ubiquitin Proteasome System in Genome Stability and Cancer

  2021cites this paper
• Elucidation of the Molecular Pathways Involved in the Protective Effects of AUY-922 in LPS-Induced Inflammation in Mouse Lungs

  2021influential citation
• Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a

  2021cites this paper
• MDM2-Driven Ubiquitination Rapidly Removes p53 from Its Cognate Promoters

  2021cites this paper
• Beta-Genus Human Papillomavirus 8 E6 Destabilizes the Host Genome by Promoting p300 Degradation

  2021cites this paper
• ATM: Translating the DNA Damage Response to Adaptive Immunity.

  2021cites this paper
• Iso-suillin-induced DNA damage leading to cell cycle arrest and apoptosis arised from p53 phosphorylation in A549 cells.

  2021cites this paper
• Trp53 ablation fails to prevent microcephaly in mouse pallium with impaired minor intron splicing

  2021cites this paper
• The spatiotemporal expression of TERT and telomere repeat binding proteins in the postnatal mouse testes

  2021cites this paper
• Ouabain Induces DNA Damage in Human Osteosarcoma U-2 OS Cells and Alters the Expression of DNA Damage and DNA Repair–associated Proteins

  2021cites this paper
• TNFα Enhances Tamoxifen Sensitivity through Dissociation of ERα-p53-NCOR1 Complexes in ERα-Positive Breast Cancer

  2021cites this paper
• A critical role for E2-p53 interaction during the HPV16 life cycle

  2021cites this paper
• Sterigmatocystin, 5-Methoxysterigmatocistin, and Their Combinations are Cytotoxic and Genotoxic to A549 and HepG2 Cells and Provoke Phosphorylation of Chk2, but not FANCD2 Checkpoint Proteins

  2021cites this paper
• DNA damage—how and why we age?

  2021cites this paper
• Roles of ATM and ATR in DNA double strand breaks and replication stress.

  2021cites this paper
• Role of RUNX Family Transcription Factors in DNA Damage Response

  2020cites this paper
• mRNAs biomarker related to the control of proliferation and cell death in HepG2/C3A spheroid and monolayer cultures treated with piperlongumine

  2020cites this paper
• The altered expression of telomerase components and telomere-linked proteins may associate with ovarian aging in mouse.

  2020cites this paper
• Cold Atmospheric Helium Plasma Induces Apoptosis by Increasing Intracellular Reactive Oxygen and Nitrogen Species

  2020cites this paper
• Maslinic Acid Induces DNA Damage and Impairs DNA Repair in Human Cervical Cancer HeLa Cells

  2020cites this paper
• Nonlinearities in the cellular response to ionizing radiation and the role of p53 therein

  2020cites this paper
• CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate

  2020cites this paper
• ATM induces radioresistance of non-small cell lung cancer A549 cells by downregulation of MDMX

  2020influential citation
• Genome‐defined African ancestry is associated with distinct mutations and worse survival in patients with diffuse large B‐cell lymphoma

  2020cites this paper
• Cellular Responses to Platinum-Based Anticancer Drugs and UVC: Role of p53 and Implications for Cancer Therapy

  2020cites this paper
• A Switch in p53 Dynamics Marks Cells That Escape from DSB-Induced Cell Cycle Arrest

  2020influential citation
• Chaperones and Ubiquitin Ligases Balance Mutant p53 Protein Stability in Esophageal and Other Digestive Cancers

  2020cites this paper
• Senescent Cell Depletion Through Targeting BCL-Family Proteins and Mitochondria

  2020cites this paper
• USP7 Is a Master Regulator of Genome Stability

  2020cites this paper
• Regulation of DNA Damage Response and Homologous Recombination Repair by microRNA in Human Cells Exposed to Ionizing Radiation

  2020cites this paper
• Casticin Induces DNA Damage and Affects DNA Repair Associated Protein Expression in Human Lung Cancer A549 Cells (Running Title: Casticin Induces DNA Damage in Lung Cancer Cells)

  2020cites this paper
• Autophagy as a cellular stress response mechanism in the nervous system.

  2020cites this paper
• Testicular cancer: Determinants of cisplatin sensitivity and novel therapeutic opportunities.

  2020cites this paper
• Roles of ATM and ATR in DNA double strand breaks and replication stress.

  2020cites this paper